Greed Pays Off for Eli Lilly

By 340B Matters The drug industry already has some of the highest profit margins of any sector and they’re getting higher for Eli Lilly. U.S. revenues increased by a whopping 26% ...

Big Pharma’s Stinking Thinking Shows in Arkansas

By 340B Matters If there were any doubts about just how idiotic Big Pharma’s arguments can be against the 340B Drug Discount Program, look no further than Arkansas where the ...

HHS Inspector General Must Find Drug Companies GUILTY

By 340B Matters The Department of Health and Human Services has referred six recalcitrant drug companies to the agency Inspector General for civil monetary penalties for denying 340B discounts to healthcare ...

340B Matters Open Letter to HHS Secretary Becerra on the Egregious Eight

By 340B Matters Dear Secretary Becerra, On August 1 and September 1, Boehringer Ingelheim and Merck respectively began denying 340B discount pricing to safety-net healthcare providers that use contract pharmacies. This is ...

Big Pharma Companies Facing Anti-Trust Liability in 340B Fight

By 340B Matters At long last, four top pharmaceutical companies are being sued under federal antitrust law for conspiring to deprive safety-net healthcare providers of lower pricing under the 340B Drug ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields